The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Market players and Sample losses their business due to the temporarily shutting down of enterprises in various regions. In this situation, pediatric imaging and other associated treatment is stopped. Biobanks are critical for speeding up research. The COVID19 collection and characterization were began by the Argentinean Biobank of Infectious Diseases (BBEI) early in the SARS-CoV-2 epidemic. Biobanks are critical components in the advancement of fundamental, preclinical, translational, and clinical research. As SARS-CoV-2 expanded over the world, there was, and continues to be, a pressing need to learn more about the virus, to comprehend and treat the wide range of clinical manifestations it causes, and to halt its transmission in humans. As a result, the scientific community's demand for samples from infected or recovered individuals, as well as the clinical data that goes with them, has increased dramatically. Latin America confronts the issue of addressing genetic variability in research to improve pharmacological responses to medicines for diseases due to its vast population diversity. The establishment of biobanks, as well as their strengthening and collaboration, would be critical in obtaining pharmacogenetic information and effective therapeutic responses in South America.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America biobanks market. The South America biobanks market is expected to grow at a good CAGR during the forecast period.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 190.08 Million |
| Market Size by 2028 | US$ 261.23 Million |
| CAGR (2021 - 2028) | 4.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product and Service
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Biobanks Market is valued at US$ 190.08 Million in 2021, it is projected to reach US$ 261.23 Million by 2028.
As per our report South America Biobanks Market, the market size is valued at US$ 190.08 Million in 2021, projecting it to reach US$ 261.23 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.
The South America Biobanks Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Biobanks Market report:
The South America Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Biobanks Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Biobanks Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Biobanks Market
